ASCL1驱动神经内分泌前列腺癌的发展
Caden N McQuillen1, Nicholas J Brady2
1Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer research
|November 4, 2024
概括
前列腺癌中针对雄激素受体 (AR) 治疗的耐药性是一个主要问题. ASCL1对于神经内分泌前列腺癌 (NEPC) 的发展至关重要,其损失将瘤细胞重定向到基本类型的表型.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 针对雄激素受体 (AR) 向剂的治疗耐药性是前列腺癌治疗中的一个重大临床挑战.
- 前列腺瘤可以通过血统可塑性和进展到神经内分泌前列腺癌 (NEPC) 逃避AR向治疗.
- 虽然遗传变化可以使瘤易患NEPC,但这种进展的基本驱动因素在很大程度上仍未确定.
研究的目的:
- 确定驱动神经内分泌前列腺癌 (NEPC) 进展的基本调节者.
- 调查ASCL1在NEPC发育和血统可塑性中的作用.
- 建立一个新的模型来研究NEPC及其表型变化.
主要方法:
- 利用基因工程小鼠模型研究前列腺癌的进展.
- 分析了ASCL1表达和损失对瘤细胞表型和血统轨迹的影响.
- 研究了ASCL1+NEPC细胞过渡到NEUROD1+状态的潜力.
主要成果:
- 发现ASCL1对于最初的瘤形成和生长是不可或缺的.
- 丢失ASCL1显著取消了NEPC的发展,将血统重定向到基底类型的表型.
- 证明ASCL1+NEPC细胞也可以表现出NEUROD1+表型,突出塑性.
结论:
- ASCL1被确定为神经内分泌前列腺癌 (NEPC) 发展的重要调节剂.
- 失去ASCL1促进前列腺癌血统可塑性的转变,有利于基底类型的表型而不是NEPC.
- 这项研究为NEPC研究提供了一个新型模型,并阐明了ASCL1调节在前列腺癌中的表型后果.
更多相关视频
10:38Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
8.9K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...